KAMADA LTD (KMDA) Stock Fundamental Analysis
NASDAQ:KMDA - Nasdaq - IL0010941198 - Common Stock - Currency: USD
KMDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 559 industry peers in the Biotechnology industry. KMDA scores excellent on profitability, but there are some minor concerns on its financial health. KMDA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
In the past year KMDA had a positive cash flow from operations.
In multiple years KMDA reported negative net income over the last 5 years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
KMDA has a better Return On Assets (4.28%) than 91.95% of its industry peers.
KMDA has a better Return On Equity (6.37%) than 93.20% of its industry peers.
With an excellent Return On Invested Capital value of 5.91%, KMDA belongs to the best of the industry, outperforming 93.38% of the companies in the same industry.
KMDA had an Average Return On Invested Capital over the past 3 years of 2.98%. This is significantly below the industry average of 14.78%.
The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(5.91%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.28% | ||
| ROE | 6.37% | ||
| ROIC | 5.91% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
KMDA has a better Profit Margin (9.60%) than 92.67% of its industry peers.
KMDA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 14.24%, KMDA belongs to the top of the industry, outperforming 94.63% of the companies in the same industry.
KMDA's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 44.23%, KMDA is doing good in the industry, outperforming 75.67% of the companies in the same industry.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.24% | ||
| PM (TTM) | 9.6% | ||
| GM | 44.23% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
Compared to 1 year ago, KMDA has about the same amount of shares outstanding.
KMDA has more shares outstanding than it did 5 years ago.
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
KMDA has an Altman-Z score of 2.87. This is not the best score and indicates that KMDA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of KMDA (2.87) is better than 73.17% of its industry peers.
The Debt to FCF ratio of KMDA is 0.30, which is an excellent value as it means it would take KMDA, only 0.30 years of fcf income to pay off all of its debts.
KMDA has a Debt to FCF ratio of 0.30. This is amongst the best in the industry. KMDA outperforms 95.71% of its industry peers.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, KMDA is doing worse than 61.00% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for KMDA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.3 | ||
| Altman-Z | 2.87 |
ROIC/WACC0.66
WACC8.91%
2.3 Liquidity
A Current Ratio of 3.30 indicates that KMDA has no problem at all paying its short term obligations.
With a Current ratio value of 3.30, KMDA is not doing good in the industry: 62.08% of the companies in the same industry are doing better.
KMDA has a Quick Ratio of 1.93. This is a normal value and indicates that KMDA is financially healthy and should not expect problems in meeting its short term obligations.
KMDA has a Quick ratio of 1.93. This is in the lower half of the industry: KMDA underperforms 75.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.3 | ||
| Quick Ratio | 1.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.09% over the past year.
The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
KMDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)26.09%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%75%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%16.65%
3.2 Future
The Earnings Per Share is expected to grow by 19.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.00% on average over the next years. This is quite good.
EPS Next Y16.71%
EPS Next 2Y22.1%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year12.1%
Revenue Next 2Y10.7%
Revenue Next 3Y9%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 23.62, which indicates a rather expensive current valuation of KMDA.
Based on the Price/Earnings ratio, KMDA is valued cheaper than 94.63% of the companies in the same industry.
KMDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.52.
Based on the Price/Forward Earnings ratio of 17.67, the valuation of KMDA can be described as rather expensive.
93.56% of the companies in the same industry are more expensive than KMDA, based on the Price/Forward Earnings ratio.
KMDA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.25, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.62 | ||
| Fwd PE | 17.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaply inside the industry as 97.67% of the companies are valued more expensively.
97.14% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.78 | ||
| EV/EBITDA | 8.65 |
4.3 Compensation for Growth
KMDA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
KMDA's earnings are expected to grow with 19.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y22.1%
EPS Next 3Y19.5%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.92%. Purely for dividend investing, there may be better candidates out there.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 109.74. KMDA pays more dividend than 98.75% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, KMDA pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.92% |
5.2 History
KMDA does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y22.1%
EPS Next 3Y19.5%
6.85
+0.07 (+1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner Change-15.53%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap393.94M
Analysts84.44
Price Target15.05 (119.71%)
Short Float %0.1%
Short Ratio0.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.92% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.18%
Min EPS beat(2)1.67%
Max EPS beat(2)28.68%
EPS beat(4)4
Avg EPS beat(4)17.92%
Min EPS beat(4)1.67%
Max EPS beat(4)38.4%
EPS beat(8)7
Avg EPS beat(8)38.21%
EPS beat(12)9
Avg EPS beat(12)-12.84%
EPS beat(16)9
Avg EPS beat(16)-100.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)2.19%
Revenue beat(4)2
Avg Revenue beat(4)1%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)4.89%
Revenue beat(8)3
Avg Revenue beat(8)0.32%
Revenue beat(12)4
Avg Revenue beat(12)-0.47%
Revenue beat(16)5
Avg Revenue beat(16)-0.1%
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)3.33%
EPS NQ rev (3m)10.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.18%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)2.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.62 | ||
| Fwd PE | 17.67 | ||
| P/S | 2.36 | ||
| P/FCF | 10.78 | ||
| P/OCF | 8.55 | ||
| P/B | 1.56 | ||
| P/tB | 1.78 | ||
| EV/EBITDA | 8.65 |
EPS(TTM)0.29
EY4.23%
EPS(NY)0.39
Fwd EY5.66%
FCF(TTM)0.64
FCFY9.27%
OCF(TTM)0.8
OCFY11.69%
SpS2.91
BVpS4.38
TBVpS3.85
PEG (NY)1.41
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.28% | ||
| ROE | 6.37% | ||
| ROCE | 7.49% | ||
| ROIC | 5.91% | ||
| ROICexc | 7.78% | ||
| ROICexgc | 8.89% | ||
| OM | 14.24% | ||
| PM (TTM) | 9.6% | ||
| GM | 44.23% | ||
| FCFM | 21.85% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.3 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 67.17% | ||
| Cap/Sales | 5.7% | ||
| Interest Coverage | 37.14 | ||
| Cash Conversion | 121.25% | ||
| Profit Quality | 227.48% | ||
| Current Ratio | 3.3 | ||
| Quick Ratio | 1.93 | ||
| Altman-Z | 2.87 |
F-Score6
WACC8.91%
ROIC/WACC0.66
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.09%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%75%
EPS Next Y16.71%
EPS Next 2Y22.1%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)11.83%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%16.65%
Revenue Next Year12.1%
Revenue Next 2Y10.7%
Revenue Next 3Y9%
Revenue Next 5YN/A
EBIT growth 1Y72.33%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year111.37%
EBIT Next 3Y35.88%
EBIT Next 5YN/A
FCF growth 1Y130.07%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y127.24%
OCF growth 3YN/A
OCF growth 5Y11.54%